NYSE : MCK

McKesson Corporation

$840.9 USD

$16.41 (1.99%)

Volume
633.28K
Average Volume
1.18M
Market Capitalization
$98.45B
P/E Ratio
21.76
Dividend Yield
0.39%
Price Target
$1010.00
Year High
$999.00
Year Low
$637.00
Day High
—
Day Low
—
Payout Ratio
$0.08
Current Ratio
$0.85
Company Overview

NYSE

Brian S. Tyler

Medical - Distribution

Healthcare

MCK

43000

US

USD

https://www.mckesson.com

972 446 4800

58155Q103

0000927653

Liquidity Metrics

-3.97

0.85

0.49

0.06

0.08

Sales & Valuation

$403.43B

0.24

-47.27

16.59

48.62

Profitability

$38.38

$4.76B

1.18%

1.54%

-265.44%

5.78%

P/E Metrics

21.76

0.45

0.45

Analyst Price Target & Rating

$1010.00

$1085.00

$875.00

Sell

2/5

31 Analysts

-16.74%

Financial Health Scores

6.09

6/9

-$9.81B

$82.32B

$83.16B

$6.29B

Key Metrics (TTM)

$103.09B

0.26

14.69

0.85

-265.44%

31.07%

4.64%

6.03%

-8 days

Company Executives
Name Title
Brian S. Tyler CEO & Chairman
Kirk Kaminsky Executive Vice President & Group President of North American Pharmaceutical Services
Napoleon Rutledge Jr. Senior Vice President, Controller & Chief Accounting Officer
Jeni Dominguez Head of Investor Relations
Joan Eliasek President of North American Pharmaceutical Distribution
Thomas L. Rodgers Executive Vice President and Chief Strategy & Business Development Officer
Michele Lau Executive Vice President & Chief Legal Officer
Paul A. Smith Senior Vice President of Taxes
Kenny K. Cheung Executive Vice President & Chief Financial Officer
LeAnn Smith Executive Vice President & Chief Human Resources Officer
Francisco Fraga Executive Vice President, Chief Information Officer & Chief Technology Officer
Kevin Kettler Executive VP & President of Prescription Technology Solutions
Kevin W. Emerson Senior Vice President of Finance Operations
Stanton McComb President of Medical-Surgical
Britt J. Vitalone Executive Officer
Poll Results

No votes yet today — be the first to share your view!

About McKesson Corporation (NYSE:MCK) Stock

McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology servic ... es, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.

Dimensional Fund Advisors LP Raises Stock Position in McKesson Corporation $MCK

2026-07-23 03:42:02

Dimensional Fund Advisors LP grew its stake in shares of McKesson Corporation (NYSE: MCK) by 1.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 356,397 shares of the company's stock after acquiring an additional 4,311 shares during the

Here's Why McKesson (MCK) Fell More Than Broader Market

2026-07-22 18:51:07

In the most recent trading session, McKesson (MCK) closed at $814.04, indicating a -1.79% shift from the previous trading day.

Is Trending Stock McKesson Corporation (MCK) a Buy Now?

2026-07-22 10:01:12

Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.

McKesson Corporation Raises Quarterly Dividend by 15% to $0.94 Per Share

2026-07-22 08:00:00

IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.94 per share of common stock, a 15% increase from $0.82 per share in the prior quarter. The dividend will be payable on October 1, 2026, to shareholders of record on September 1, 2026. “Today's announcement marks our tenth consecutive year of dividend growth, reflecting the strength of our business, our disciplined approach to capital allocation and our commitmen.

Here's Why McKesson (MCK) is a Strong Growth Stock

2026-07-21 10:46:06

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

McKesson (MCK) Declines More Than Market: Some Information for Investors

2026-07-20 19:01:13

McKesson (MCK) closed at $831.46 in the latest trading session, marking a -1.18% move from the prior day.

Here's Why McKesson (MCK) is a Strong Value Stock

2026-07-15 10:40:47

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

McKesson (MCK) Stock Dips While Market Gains: Key Facts

2026-07-14 19:01:10

McKesson (MCK) closed at $803.37 in the latest trading session, marking a -1.1% move from the prior day.

Frequently Asked Questions

What is the current McKesson Corporation (MCK) stock price?

McKesson Corporation(NYSE:MCK) stock price is $840.9 in the last trading session. During the trading session, MCK stock reached the peak price of $999 while $637 was the lowest point it dropped to. The percentage change in MCK stock occurred in the recent session was 1.99% while the dollar amount for the price change in MCK stock was $16.41.

MCK's industry and sector of operation?

The NYSE listed MCK is part of Medical - Distribution industry that operates in the broader Healthcare sector.

Who are the executives of MCK?

Brian S. Tyler | CEO & Chairman
Kirk Kaminsky | Executive Vice President & Group President of North American Pharmaceutical Services
Napoleon Rutledge Jr. | Senior Vice President, Controller & Chief Accounting Officer
Jeni Dominguez | Head of Investor Relations
Joan Eliasek | President of North American Pharmaceutical Distribution

How many employees does MCK have?

Number of MCK employees currently stands at 43000. MCK operates from 6555 State Highway 161, Irving, TX 75039, US.

Link for MCK official website?

Official Website of MCK is: https://www.mckesson.com

How do I contact MCK?

MCK could be contacted at phone #972 446 4800 and can also be accessed through its website. MCK operates from 6555 State Highway 161, Irving, TX 75039, US.

How many shares of MCK are traded daily?

The average number of MCK shares traded daily for last 3 months was 1.18M.

What is the market cap of MCK currently?

The market value of MCK currently stands at $98.45B with its latest stock price at $840.9